BIOSCIENCE NEUTRACEUTICALS, INC. Proceeds from Convertible Debt
BIOSCIENCE NEUTRACEUTICALS, INC. reported Proceeds from Convertible Debt of $37.14 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2020-03-30
- BIOSCIENCE NEUTRACEUTICALS, INC. proceeds from convertible debt for fiscal 2019 was $37.14K.
- BIOSCIENCE NEUTRACEUTICALS, INC. proceeds from convertible debt for fiscal 2017 was $22.88K.
| Period end | Proceeds from Convertible Debt 12 month |
|---|---|
| 2019-12-31 | $37.14K 10-K · filed 2020-03-30 |
| 2017-12-31 | $22.88K 10-K · filed 2019-04-09 |